The carrier state: Neisseria meningitidis.
D001428:Bacterial Vaccines; D002353:Carrier State / Q000188:drug therapy / Q000453:epidemiology* / Q000382:microbiology; D004352:Drug Resistance, Microbial; D006801:Humans; D008585:Meningitis, Meningococcal / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D022401:Meningococcal Vaccines; D008911:Minocycline / Q000627:therapeutic use; D009345:Neisseria meningitidis / Q000302:isolation & purification; D009549:Nigeria; D012293:Rifampin / Q000627:therapeutic use; D013411:Sulfadiazine / Q000627:therapeutic use; D014481:United States
D001428:Bacterial Vaccines; D022401:Meningococcal Vaccines; D013411:Sulfadiazine; D008911:Minocycline; D012293:Rifampin